ArticleEBioMedicine2025

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials.

Christopher L Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.